IHealthScreen hauled in FDA 510(k) clearance for its AI-powered diagnostic that detects mild diabetic retinopathy in diabetic ...

HealthScreen, Inc., a healthcare AI company developing Software as a Medical Device (SaMD) for retinal and cardiovascular disease screening and preventive healthcare, today announced FDA 510(k) ...

The company's software analyses images captured by the iCare DRSplus camera, a tool widely used in ophthalmology clinics and ...

DR, an AI-powered screening software designed to detect more than mild diabetic retinopathy in adults with diabetes, ...

For decades, the management of diabetic retinopathy (DR) has consisted mainly of optimizing metabolic control (blood glucose, pressure and lipids) and routine surveillance as preventive strategies, ...

Incorporation of an artificial intelligence-based-optical coherence tomography (AI-OCT) system as a secondary screening tool is noninferior to standard practice and can reduce unnecessary diabetic ...

Incorporation of an artificial intelligence based-optical coherence tomography (AI-OCT) system as a secondary screening tool is noninferior to standard practice and can reduce unnecessary diabetic ...

A SKIN cancer detecting AI app trialled in the NHS can now be run entirely through a standard smartphone, inventors say. Clinics typically used a camera lens attachment to take photos of suspicious ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.